Lilongwe District Health Office (DHO) has embarked on a Bilharzia drug mass distribution campaign in order to eliminate the disease in the district.
Sign up for Nthanda Times
Top Stories Newsletter
Politics, education, health, and more—get the latest news that matters most to you.
Advertisement
protected by reCAPTCHA
Advertisement
Speaking Tuesday during a media briefing in Lilongwe, District Health Promotion Officer, Richard Mvula, said the exercise which started on Tuesday, March 5, is expected to end on March 9.
“We are targeting school going children from the age of six upwards as well as adults. At the end of the exercise we are expected to reach out to 800,000 people in the district,” he said.
He appealed to parents to sensitise their children to take the drugs at school once it is administered.
Advertisement
Mvula captured during the media briefing
“Bilharzia is one of the diseases which has been earmarked for elimination just like we did with other neglected tropical diseases such as Lymphatic IASIS. That is why we have decided to conduct this campaign so that no one is left behind and declare Malawi free from Bilharzia,” he said.
Currently, Lilongwe DHO is working hand in hand with Ministry of Education by going to each and every school meeting primary school learners.
Mvula said, in the communities they will be going around in places where people usually meet and also engage volunteers on door to doors services.
Advertisement
Malawi Health Equity Network (MHEN) Chief Executive Officer, George Jobe, welcomed the intervention saying it has come at the right time when the country is still receiving rains.
“Knowing that Bilharzia has affected Malawi for a long time, it is very encouraging that the country aims at eliminating the disease. My appeal to parents and stakeholders is to positively welcome the intervention,” he said.
The campaign is being conducted in three districts of Blantyre, Zomba and Lilongwe.
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.